| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Origin Materials, Inc. | Interim CFO | Common Stock | 136,650 | $105,849 | $0.7746 | 01 Sep 2023 | Direct |
| Arcadia Biosciences, Inc. | Chief Financial Officer | Stock Option (right to buy) | 255,313 | 16 Aug 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| ORGN | Origin Materials, Inc. | 01 Sep 2023 | 1 | $0 | 4 | Interim CFO | 06 Sep 2023, 16:17 |
| ORGN | Origin Materials, Inc. | 01 Sep 2023 | 0 | $0 | 3 | Interim CFO | 06 Sep 2023, 16:16 |
| RKDA | Arcadia Biosciences, Inc. | 16 Aug 2022 | 1 | $0 | 4 | Chief Financial Officer | 18 Aug 2022, 20:56 |
| RKDA | Arcadia Biosciences, Inc. | 01 Aug 2022 | 1 | +$490 | 4 | Chief Financial Officer | 03 Aug 2022, 17:23 |
| RKDA | Arcadia Biosciences, Inc. | 11 Apr 2022 | 2 | $0 | 4 | Chief Financial Officer | 13 Apr 2022, 15:55 |